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EFFICACY AND SAFETY OF POST PARTUM INSERTION OF 
IUCD AMONG PARTURITENTS 
 
                                                                    
  
EFFICACY AND SAFETY OF PPIUCD AMONG PARTURITENTS 
ABSTRACT 
Aim:To determine the safety and efficacy of postpartum insertion of IUCD among 
parturitents. 
Methods: CuT 380A were inserted within 10 min after postplacental expulsion and 
48 hours post partum both in vaginal and cesarean deliveries based on the medical 
eligibility criteria. Out of 300 woman, only 259 returned for follow up..They are  
given education regarding complications at discharge and counselled for follow up 
at 3 months and 6months and at 12months.  
Results:The follow up rate at 3months, 6 months and at 12 months are 
72.6%,76.3%, 74.3% respectively.The continuation rates at 6& 12 months are-
95.6%, 93.2% respectively. There are no pregnancy  nor perforations at the end of 
1 year. The discontinuation rate means it includes both spontaneous expulsion and 
removal due to medical problems.The  annual cumulative expulsion  rate 2% and 
the annual removal rate 2.3%. 
 Conclusion: The evidence from this study suggests that immediate postplacental 
insertion of CuT 380A  is an effective, useful, safe, convenient and low-cost 
procedure for early postpartum contraception  
Keywords: Intrauterine device; Postplacental insertion 
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INTRODUCTION 
The intrauterine contraceptive device is one of the most widely 
used method of reversible fertility regulation with more than hundred 
million users worldwide. 
The population in India has been growing rapidly which will reach 
1.53 billion by 2050. Approximately 248 million women belong to the 
age group of 15-49 years.  The main objective of the family planning 
program is to promote adequate spacing of births, by providing high 
quality of contraceptive services. 
According to NFHS –3, the prevalence rate of birth control in India 
is 56.3 %, and the unmet need is high (13%) with 6% for spacing. 
        Review of literature have showed that IUCDs are very effective, 
safe and offers long-term protection against pregnancy with negligible 
health risks. 
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Global use of IUCD  
          Recent data shows that almost one in every five married couples 
are using an IUCD. 
  
 
 
  
GLOBAL USE OF IUCD AMONG 
REPRODUCTIVE AGE WOMAN
CHINA 60%
OTHER ASIAN COUNTRIES 
12%
EASTERN EUROPE 11%
NORTH EAST & NORTH 
AFRICA 7%
LATIN AMERICA & 
CARRIBBEAN 5%
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 Indian scale of IUCD 
Earlier in 1965 ,the  Government of India, introduced Lippes 
Loop,which was considered as an important spacing method. Later on the  
as per the results of clinical trials conducted by the Indian Council of 
Medical Research in 1972, Copper T 200 B was introduced in 1975. In 
1997, ICMR  again conducted a comparative study between IUCD 200B 
and 380A as CuT 380A was introduced in2002,  which had replaced CuT 
200B in that programme. 
Now the government is offering  IUCD services free of cost,  under 
JHPIEGO( Johns Hopkins program for international education in 
Gynaecology & obstetrics), which was implemented in 2009,it still 
remains largely underutilized. 
 
IUCD USE IN INDIA
IUCD
CONDOM
PILL
FEMALE STERLISATION
MALE STERLISATION
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INTRA UTERINE CONTRACEPTIVE DEVIC 
The IUCD was first introduced by Graffenberg in 1909. 
Subsequently, Jack  Lippes developed the Lippes Loop in the 1960s , 
which became the  most commonly  used IUCD in many countries. 
When  Copper T IUCD 380 A came into being, it has become one 
of the  best known and most widely used IUCDs in the world which  is  
available in many countries. It is a T shaped device made  up of 
polyethylene and impregnated with barium sulfate to render it radio 
opaque for visibility on X-ray. It is 3.6 cm in length and 3.2 cm in width. 
The copper wire is wound around in each horizontal arm as well as in the 
vertical stem. copper is released high in the fundus of the uterus at the 
rate of 50µg/day .  A thin polyethylene string is attached to the bottom of 
the stem for easy removal.  
 
MECHANISM OF ACTION 
Copper T 380A, acts primarily by preventing fertilization. The 
released Copper  decreases sperm motility and  alters the enzymatic and 
metabolic changes in  the uterus and fallopian tube, there by preventing 
sperm from reaching the fallopian tubes and fertilizing the ovum.It also 
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also stimulates foreign body reaction in the endometrium that causes  
macrophage release and prevents implantation of the fertilized ovum. 
The effectiveness is dependent on the annual failure (pregnancy) 
rate. Copper T380 A  has an effective life of upto 10 years. A woman’s 
fertility returns immediately after an IUCD is removed . 
 
ADVANTAGES 
 Convenient for the woman as it  saves time and no additional visits 
are needed, as well as for the inserter for the easy integration of 
services. 
 Safe because it is certain that she is not pregnant at the time of 
insertion 
 High motivation from both woman and family is needed. 
 Risk of uterine perforation is negligible because of the thick wall of 
the uterus. 
 Decreased perception of initial side effects like bleeding and 
cramping. 
 Doesn’t  affect the amount or quality of breast milk 
 It is very effective and is immediate  
 Provides a healthy birth spacing interval, there by reduces 
morbidity and mortality of mother and newborn. If the birth to 
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pregnancy interval is < 6 months, there is increased risk of 
misscarriage,induced abortion,and maternal mortality .Birth to 
pregnancy interval of < 24 months are associated with higher infant 
neonatal mortality. 
 A single decision is enough to provide  long-term prevention of 
pregnancy. 
 There are no hormonal side effects with copper-bearing IUCD. 
 Risk of ectopic pregnancy are minimal than in women not using 
any family planning method. 
  
LIMITATIONS 
 Increased risk of spontaneous expulsion 
 Spontaneous expulsion rates for PPIUCD are dependent upon 
insertion technique and the skill of the provider.  
           The rate of expulsion  vary widely in the range of 10 – 14%. A 
well skilled inserter and the insertion technique reduces expulsion rates to 
2 – 5%.  
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REVIEW OF LITERATURE 
1. Ory HW, for Women’s Health study , Showed there is 80%-90% 
reduction in the risk of ectopic pregnancy due to  higher dose of 
copperT380A 
 
2. The Oxford study Vessey M, Doll R, Peto R , et al ,Found  that 
women gave birth just as promptly after IUCD removal as they did 
after discontinuing use of the diaphragm. 
 
3. A Cochrane data base – Grimes DA, Lopez LM et al 2006, The 
discontinuation for pain and bleeding is higher with copper IUCD. 
The worsened periods often occur with the first few menses and 
they are treated with NSAID’S. 
 
4. A Cochrane Database- Celen S , Sucak A et al 2004, Clinical 
outcomes in early postplacental insertion of IUCD.It appears to be 
safe, effective and there were no bleeding, infection nor perforation 
The main  disadvantage was   increased expulsion , and it was 
12.3% at 1 year with the copper T. 
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5. A Randomised control trial Trussel et el 2004, Showed insertion of 
IUCD after immediate postpartum period and before 4 weeks 
postpartum was associated with more perforations. Therefore it 
should be inserted within 10 minutes of placental delivery or after 
4 weeks.the failure (pregnancy ) rate of 0.8% at the end of 1 year 
of use. 
 
6. Walsh T, Grimes D, Friezieres R, Randomised Control Trial  of  
prophylactic  antibiotics before insertion of IUCD-1998. No role in 
lowering the peri-insertion infections. 
 
7. Rosenberg MJ, Waugh MS, A prospective evaluation of 
discontinuation  between oral contraception and IUCD 1998,The 
continuation rate at the end of 1 year for Copper T 380A- 78%, 
OCP- 50%. 
 
8. French R, Van Vliet H, Cowan F et al 2004- A Cochrane Database 
of pregnancy rates. The pregnancy rates at end of 1 year, CopperT  
380 A- 0.8-0.6 and LNG IUS- 0.1.per 100 woman years. 
 
9. Otero- Flores JB , Guerrero- Carreno FJ,Vazquez-Estrada LA 
2003. A large Comparative Randomised Control Study of three 
different IUCD in nulliparous Mexican woman,The high 
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effectiveness with  a failure rate at 1year and overall expulsion 
rates were 1.8%- T Null and multiload, compared with CopperT 
380A- 3.3%. 
 
10. Hubacher D, Grimes DA 2005.In a recent cohort study of 
2,037,883 woman years of follow up in china was associated with a 
decreased risk of endometrial cancer with an adjusted odds ratio of 
0.6 (95% CI 0.3-0.9).although type of IUCD were not specified, it 
was a combination of  Copper T380A, and stainless steel rings 
were most frequently used device. 
 
11. Cole et al,Expulsions in Immediate Postpartum Insertions of 
Lippes Loop D and Copper T IUDs and their Counterpart Delta 
Devices-- An Epidemiological Analysis1984. They have founded 
that postpartm insertion to be a safe procedure. the magnitude of 
IUD expulsions in postpartum depend upon  the insertor’s skill & 
experience. 
 
 
12. Comparitive study between two techniques used in immediate 
postplacental insertion of TCu 380A in china : Chen Y yang X et al 
1999 . This  is a 36-month follow-up study which comprises 384 
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women who delivered vaginally and copper T-380A  IUD  was 
inserted within 10 minutes after delivery. A total of 189 IUDs were 
inserted by hand; 195 were inserted by ring forceps. Expulsion and 
other discontinuation rates were compared at 6, 12, 24, and 36 
months post-insertion.There are no uterine perforation nor 
infection. There were 67 cases of expulsion, which was the main 
reason for the discontinuation. The gross cumulative expulsion 
rates for the manual insertion group after 6, 12, 24, and 36 months 
were 8.61, 13.55, 15.78, and 16.90 per 100 women, respectively. 
The gross cumulative expulsion rates for the ring forceps insertion 
group were 12.99, 17.23, 17.77, and 18.34 per 100 women, 
respectively. The differences between the two groups were not 
statistically significant.  
 
13. A women’s Health study – kriplani A,Buckshee K, Relan S, et al, 
showed the only pelvic infection that has been unequivocally  
related to IUCD use is actinomycosis and that to occurred in the 
women who have multiple sexual partners.The rate increases with 
duration of use of  plastic devices, and it is much less for copper 
releasing IUCD’s. 
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14. O’hanley K, Huber Dh   April 2007, New York. Insertion at 
immediate postplacental and postpartum periods are demonstrably 
safe, because they have a low incidence of infection, few bleeding 
problems, and low perforation rates.  
 
In their study expulsion rates of about 7-15 per 100 users at 
six months in a well experienced and a skilled inserter. Most 
investigators have found  that high fundal IUD placement will 
reduce the expulsion rate. Unplanned pregnancy rates range from 
2.0-2.8 per 100 users at 24 months with modern copper IUDs. It 
appears that manual or ring forceps insertion result in very low 
perforation rates, e.g., 1/1150 immediate postpartum IUD 
insertions in 1 study. 
 
15. In studies comparing immediate postpartum IUD insertions with 
interval insertions, the removal rate due to bleeding is lower for the 
immediate postpartum IUD insertions, e.g., 13.7% vs. 23.6% in a 
study in India. 90-95% of women are able to detect their own 
expulsions. 
 
16. Randomised comparative study between immediate postpartum 
insertion of multiload Cut375 and Cut380A Lara ricalde et al 2006- 
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The expulsion rates were 10.4 for the MLCu 375 and 7.7 for the 
TCu 380A . The removal rates for bleeding and pain were 4.9 and 
4.8, the removal rates for non medical reasons were 3.7 and 4.9 
respectively. There was one case of genital infection in the MLCu 
375 group. There were no pregnancies, nor uterine perforation. The 
one year continuation rates were 77.1 and 82.6 respectively. There 
were no statistical significant differences in the comparative rates. 
 
17. Randomised comparative study  of two techniques used in 
immediate postplacental insertion of the Copper T-380A IUD in 
Shanghai, Rivera R et al,1996-: IUD inserted by hand and IUD via 
ring forceps. Expulsions were the main reason for discontinuation. 
The six-month gross cumulative expulsion rates were 13.3 and 12.7 
per 100 women in the hand-insertion group and ring forceps-
insertion group, respectively.  
 
Discontinuation rates for medical removals (bleeding/pain) 
were 2.1 and 1.0 in these two groups, respectively. Neither of the 
differences was statistically significant (p > 0.05). No uterine 
perforation, infection or pregnancy occurred.  
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18. The IUD expulsion rate was higher in non-breast feeding women 
than in breast-feeding women (22.4% vs. 11.9%; p 0.05).   
 
19. Comparison of efficacy and complications of IUD insertion in 
immediate postplacental/early postpartum period with interval 
period: 1 year follow-up. Taskin L haberal A etal 2006.This study 
aimed to compare immediate postplacental and early postpartum  
insertions with interval  IUD insertions with respect to efficacy and 
complications.  The study group consisted of 268 women in whom 
the following TCu 380A IUD insertions were performed: 84  (less 
than 10 min), 46 (10 min to 72 h) and 138  (more than 6 weeks). 
The women were followed up 8 weeks, 6 months and 12 months 
after insertion. Although no statistically significant difference was 
found between the groups for uterine perforation and infection 
(p>.001), there was a statistically significant difference between 
the groups in the incidence of expulsion rates.  
 
The overall cumulative pregnancy rate and frequency of 
pregnancy were found to be higher (p>.05 for both), which are both 
insignificant for the EP group (2 of 43 women), as compared with 
the INT (4 of 130 women) and IPP groups (2 of 84 women), and 
pregnancy rates at 1 year for all groups was 3.1% (8 of 257 
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women). Immediate & early postpartum insertions are  effective 
and convenient procedure but the  expulsion rates  are higher than 
in the interval insertion group. 
 
20. In a longitudinal international study  which was conducted by the 
WHO, where the average annual pregnancy rate was 0.4%, and the 
average cumulative pregnancy rate was 2.2% at the end of 12 years 
of use of CuT 380A, which is very similar to that of tubal 
sterilization (United Nations Development Programme et al. 1997). 
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AIM OF STUDY 
To determine the safety and efficacy of postpartum insertion of 
IUCD among parturitents. 
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MATERIALS AND METHODS 
TYPE OF STUDY: 
A descriptive longitudinal study among parturitents 
 
DURATION OF STUDY:  
November 2012 to October 2013 
 
MATERIALS & METHODS: 
This is a hospital based prospective study conducted at Institute of 
social obstetrics and Government kasturba Gandhi hospital for women 
and children, Triplicane, Chennai-5 from November 2012 to October 
2013. 
   This study comprises study subject of 300 parturitents, who are 
willing for postpartum insertion of IUCD after getting written informed 
consent.The Chi-square test was used for the evaluation of the data. 
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INCLUSION CRITERIA: 
All woman who were delivered in the study period 
 
EXCLUSION CRITERIA: 
1. Those woman who were delivered not willing for PPIUCD 
2. Fever during labour 
3. Premature rupture of membranes for more than 12 hours. 
4. Chorioamnionitis 
5. Active lower genital tract infections 
6. AIDS 
7. Allergy to copper 
8. Uterine anamolies 
9. Uterine abnormalities like  myoma uterus 
10. Manual removal of placenta 
11. Post partum haemorrhage-uterine atony,traumatic  
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MEDICAL ELIGIBILTY CRITERIA 
 It describes IUCD use for women under specific medical 
conditions .The reproductive rights of the individual must be considered.  
It is essential that the provider has to screen the women based on the 
MEC in order to provide the quality care in IUCD services. There are 
four categories. 
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CATEGORY 1: Can use the IUCD with no restrictions.  
 less than 48 hours postpartun 
 Age: greater than 20 years 
 Parity 1 or more 
 Irregular menstrual cycles without heavy menstrual bleeding 
 Cigarette smoking 
 Obesity  
 History of hypertension 
 Previous history of Thromboembolic disease  
 Hyperlipidemias 
 Uncomplicated valvular heart disease 
 Epilepsy 
 Depression 
 Benign ovarian tumors 
 Cervical intraepithelial neoplasia 
 Benign breast disease or breast cancer 
 Women taking antibiotics or anticonvulsants 
 Thyroid, liver or gallbladder disease or diabetes 
 Malaria 
 Non-pelvic tuberculosis 
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 History of a prior ectopic pregnancy 
 Previous history of pelvic inflammatory disease 
 Previous caesarean section. 
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CATEGORY 2:  IUCD used with caution.It means that advantages 
generally outweigh the risks,so additional care/follow-up will be needed 
 From age of menarche to <20 years, 
 Nulliparity 
 Heavy or prolonged vaginal bleeding 
 Anatomical abnormalities  that do not distort the uterine cavity 
 Any active lower genital tract infection should be treated,and then 
inserted 
 Have a past history of PID without a subsequent pregnancy. 
 Clinically well HIV infected women 
 Symptomatic AIDS women,  on  antiretroviral therapy  
 Immediately following a second-trimester abortion either 
spontaneous or induced with  no evidence of infection.  
 Complicated valvular heart disease e.g., artificial shunts, rheumatic 
heart disease. prophylactic antibiotics are given to prevent 
endocarditis. 
 Anemic women, as copper-bearing IUCDs are associated with 
increased menstrual blood loss. 
 Women with 1st and 2nd degree uterine prolapse 
 Rectovaginal fistula 
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CATEGORY 3:  IUCD  use is not recommended as risks generally 
outweigh the advantages. 
 Heavy/prolonged menstruation, endometriosis, or severe 
dysmenorrheal. 
 After 48 hours to 6 weeks postpartum. 
 Benign trophoblastic disease. 
 Ovarian cancer  
 Women with multiple sexual partners as they are at high  risk for 
gonorrhoea or Chlamydia( purulent cervical discharge)  
 Symptomatic AIDS not on ARV therapy. 
 Women with 3rd degree uterine prolapse . 
 Women with Vesicovaginal fistulas  
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CATEGORY 4:  IUCD is contraindicated in 
 Pregnant women 
 Puerperal sepsis or  septic abortion 
 With malignant trophoblastic disease. 
 Cervical or endometrial/uterine cancer 
 Anatomical abnormalities  or submucosal myomas that distort the 
uterine cavity    
 Pelvic tuberculosis. 
 Unexplained vaginal bleeding . 
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MATERIALS NEEDED 
No extra instruments are needed, except for kellys placental 
forceps, sponge holding forceps,  and sims vaginal retractor.  
 Stainless Steel tray with cover 
 Kellys placental forceps 
 Sponge holding forceps 
 Sim’s  vaginal retractor 
 Disposable surgical gloves  
 Antiseptic solution 
 Preloaded Copper T380A 
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TIME OF INSERTION 
 There are three types of postpartum insertion of intrauterine device. 
They  are  
1. Immediate post placental 
 Insertion within 10 minutes of delivery of the placenta     
vaginal delivery 
 Intracesarean insertion 
2.Within 48 hours of delivery 
 
TECHNIQUE OF IUCD INSERTION 
 Labour natural-Within 10 minutes of the delivery of the 
placenta.under strict aseptic precautions, sims vaginal retractor is 
taken to retract the vaginal walls and the anterior lip of the cervix is 
held by the sponge holding forceps, now the preloaded IUCD is 
inserted into the uterus with the help of kellys placental forceps. 
 Intracesarean –after the placental delivery and after one third 
closure of the uterine incision, the IUCD taken in the hand is 
inserted high up in the fundus of the uterus, the threads are directed 
towards the sutured uterine wound, and note that thread should not 
be directed towards the os. Now the remaining two thirds uterine 
wound is closed in layers. 
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 48 hours post partum- Under strict aseptic precautions loaded 
IUCD is inserted with help of forceps. 
Strict adherence of  “no-touch” technique is followed  to decrease the risk 
of infections. Loaded IUCD should not touch the nonsterile surfaces. In 
all the procedure the threads not trimmed. 
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PROPER DISPOSAL 
Dispose the waste materials like cotton balls and disposable gloves 
in a leakproof container . 
 
 
 
 
 
 
 
10 minutes of delivery of the placenta-
labour natural or intra cesarean
48 
hourspost 
partum
4 - 6 weeks.
Increased rate of 
expulsion and perforation  
Ideal time for IUCD 
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AGE DISTRIBUTION
18-20
21-25
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RESULTS & ANALYSIS 
TABLE 1 
AGE  DISTRIBUTION 
AGE  GROUP FREQUENCY PERCENTAGE 
18-20      years 44 14.7 
21-25     years 162 54.0 
26-30     years 72 24.0 
Above 30    years 22 7.3 
   
 Among the 300 woman under study majority were in the 21-25 years. 
The mean age in this study is 24 years, 54%. 
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TABLE 2         
 EDUCATION DISTRIBUTION 
EDUCATION FREQUENCY PERCENTAGE 
Illiterate 24 8.0 
Primary school 73 24.3 
Middle school 117 39.0 
High School 48 16.0 
Graduate 38 12.7 
 In this study, the mean education is middle school.39% 
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PARITY   DISTRIBUTION
primipara
para 2
para 3 above
 
 
35 
 
TABLE 3 
PARITY DISTRIBUTION 
PARITY FREQUENCY PERCENTAGE 
Primi para 210 70.0 
Para 2 82 27.3 
Para 3 and above 8 2.7 
The mean parity is primi para 70 %. 
 
TABLE  4 
REQUEST / COUNSELLING DISTRIBUTION 
REQUEST / COUNSELLING FREQUENCY PERCENTAGE 
Patient’s request 93 31.0 
Husband’s request 2 0.7 
Counselling 205 68.3 
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TABLE  5 
TIME OF COUNSELLING DISTRIBUTION 
TIME OF COUNSELLING FREQUENCY PERCENTAGE 
Antepartum 99 33.0 
Intrapartum 194 64.7 
Postpartum 7 2.3 
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SOCIO ECONOMIC STATUS 
DISTRIBUTION
< 2000
2000-5000
>5000
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TABLE  6 
SOCIOECONOMIC STATUS  DISTRIBUTION 
INCOME/MONTH FREQUENCY PERCENTAGE 
< 2000 13 4.3 
2000-5000 228 76.0 
> 5000 59 19.7 
 
Low income group of less than 2000/month constitutes only 13 
members.(4.3%). 
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MEDICAL DISORDER
nil
anaemia
pregnancy induced 
hypertension
gestational diabetes melliteus
heart disease
seizure disorder
hypothyroidism
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TABLE 7 
MEDICAL DISORDER PERCENTAGE 
Nil 78.7 
Anaemia 4.3 
Pregnancy induced hypertension 8 
Gestational diabetes meliteus 5.7 
Heart disease 1.7 
Seizure disorder 1 
Hypothyroidism 3 
Residual polio 0.3 
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TABLE 8 
PREVIOUS H/O OF CONTRACEPTIVE USE 
 
PREVIOUS HISTORY OF 
CONTRACEPTIVE USE 
FREQUENCY PERCENTAGE 
None 235 78.3 
IUCD 53 17.7 
Others 12 4 
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MODE OF DELIVERY DISTRIBUTION
labour natural
instrumental delivery
cesarean section
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TABLE 9 
MODE OF DELIVERY DISTRIBUTION 
MODE OF DELIVERY FREQUENCY PERCENTAGE 
Labour natural 66 22 
Instrumental delivery 2 0.7 
Caesarean section 232 77.3 
In our study,77.3% were csarean section and 22% were labour natural. 
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TIME OF INSERTION DISTRIBUTION
within 10 minutes
intracesarean
48 hours post partum
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TABLE 10 
TIME OF INSERTION DISTRIBUTION 
TIME OF INSERTION FREQUENCY PERCENTAGE 
Within 10 minutes 35 11.7 
Intra-cesarean 232 77.3 
48 hours postpartum 33 11.0 
In this study, 77.3% were intracesarean  insertion and  among 22%  of 
labour natural only 11.7%  insertion were witin 10 minutes of placental 
delivery. 
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FOLLOW UP DISTRIBUTION
not returned
at 3 months
at 6 months
at 12 months
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TABLE 11 
FOLLOW UP DISTRIBUTION 
FOLLOW UP FREQUENCY PERCENTAGE 
At 3 months 218 72.7 
At 6 months 249 76.3 
At 12 months 223 74.3 
Not returned 41 13.7 
Among the 300 woman, only 74.3% followed up at the end of 1 year.not 
returned for follow up constitutes 41(13.7%). 
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TABLE 12 
REGAINED MENSTRUAL CYCLES 
REGAINED MENSTRUAL 
CYCLES 
FREQUENCY PERCENTAGE 
Yes 71 23.7 
No 188 62.7 
 
TABLE 13 
BREAST FEEDING 
BREAST   FEEDING FREQUENCY PERCENTAGE 
Exclusive breast feeding 215 71.7 
Combined feeds 44 14.7 
 
 
  
 
 
49 
 
 
 
 
 
 
 
  
COMPLICATIONS DISTRIBUTION
nil
expulsion
intermenstrual spotting
white discharge, pain 
abdomen
reinsertion 
permanent sterilisation
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TABLE 14 
COMPLICATIONS DISTRIBUTION 
COMPLICATIONS FREQUENCY PERCENTAGE 
Nil 208 69.3 
Expulsion followed by no 
reinsertion 
5 1.7 
Inter menstrual spotting 18 6.0 
White discharge, pain 17 5.7 
Expulsion followed by Re -
insertion 
1 0.3 
Permanent sterlisation 3 1.0 
Removed 7 2.3 
At the end of 12 months , among the 300 woman 41 persons not returned 
for follow up itself, there are no pregnancy nor perforations.with the  
cumulative expulsion rate of 1.7% +0.3%=2% and the discontinuation 
rate is 2.3%. 
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TABLE 15 
THREAD VISIBILITY DISTRIBUTION 
THREAD VISIBILTY FREQUENCY PERCENTAGE 
Yes 150 57.9 
No 109 42.1 
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TABLE 16 
MISSING THREAD CONFIRMED BY 
ULTRASONOGRAM  DISTRIBUTION 
MISSING THREAD 
CONFIRMED BY 
ULTRASONOGRAM 
FREQUENCY PERCENTAGE 
Yes 94 36.2 
No 5 1.9 
 
Among 259 woman , 109 (42.1%)woman, Copper T thread was not 
visible in the follow up on per speculum examination.so transabdominal 
sonogram was done, to rule out any perforations.in the 109 woman,3 
permanent sterilisations, 7 removal were excluded and only  for 99 
woman trans abdominal sonogram was done.94(36.2%) had CuT was 
insitu in the uterus.Remaining 5 persons had no Copper T , which 
confirmed, it was spontaneously expulled and no perforations were there. 
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TABLE 17 
AGE IN GROUPS  & COMPLICATIONS 
CROSS  TABULATION 
COMPLICATIONS 
AGE IN GROUPS 
TOTAL 
18-20 21-25 26-30 >30 
Nil count 
% of total 
31 
79.5% 
113 
82.5% 
48 
75% 
16 
84.2% 
208 
80.3% 
Expulsion count 
% of total 
0 
.0% 
4 
2.9% 
1 
1.6% 
0 
.0% 
5 
1.9% 
Inter menstrual 
spotting count 
% of total 
3 
7.7% 
3 
2.2% 
10 
15.6% 
2 
10.5% 
18 
6.9% 
White discharge 
count 
% of total 
4 
10.3% 
10 
7.3% 
2 
3.1% 
1 
5.3% 
17 
6.6% 
Re-insertion count 
% of total 
0 
.0% 
0 
0.0% 
1 
1.6% 
0 
.0% 
1 
0.4% 
Permanent 
sterilisation count 
% of total 
0 
.0% 
2 
1.5% 
1 
1.6% 
0 
.0% 
3 
1.2% 
Removed count 
% of total 
1 
2.6% 
5 
3.6% 
1 
1.6% 
0 
.0% 
7 
2.7% 
TOTAL 
39 
15.1% 
137 
52.9% 
64 
24.2% 
19 
7.3% 
259 
100% 
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 According to the above data, as the age  increases, there is increased 
continuation rate with no expulsion and removal, but  expulsion & 
removal rates  are high in the 21-25 years age group which is due to the 
increased pain abdomen and white disharge. 
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TABLE 18 
PARITY & COMPLICATIONS 
CROSS TABULATIONS 
COMPLICATIONS 
PARITY 
TOTAL 
Primipara Para 2 
Para 3and 
above 
Nil  count 
% of total 
142 
80.7% 
60 
77.9% 
6 
100% 
208 
80.3% 
Expulsion count 
% of total 
4 
2.3% 
1 
1.3% 
0 
.0% 
5 
1.9% 
Intermenstrual spotting 
count 
% of total 
10 
5.7% 
8 
10.4% 
0 
.0% 
18 
6.9% 
White disharge count 
% of total 
14 
8.0% 
3 
3.9% 
0 
.0% 
17 
6.6% 
Re-insertion count 
% of total 
0 
.0% 
1 
1.3% 
0 
.0% 
1 
0.4% 
Permanent sterilisation 
count 
% of total 
0 
.0% 
3 
3.9% 
0 
.0% 
3 
1.2% 
Removed count 
% of total 
6 
3.4% 
1 
1.3% 
0 
.0% 
7 
2.7% 
TOTAL 
176 
68% 
77 
29% 
6 
2.3% 
259 
100% 
According to the above data,removal rate, expulsion rate and white 
disharge are more with the primiparity. 
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PARITY & COMPLICATIONS 
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TABLE 19 
SOCIOECONOMC STATUS AND COMPLICTIONS                                                           
CROSS TABULATION 
COMPLICATIONS 
SOCIOECONOMIC STATUS 
TOTAL 
<2000 2000-5000 >5000 
Nil count 
% of total 
7 
58.3% 
164 
81.6% 
37 
80.4% 
208 
80.3% 
Expulsion count 
% of total 
0 
0% 
4 
2% 
1 
2.2% 
5 
1.9% 
Intermenstrual spotting 
count 
% of total 
2 
16.7% 
11 
5.5% 
5 
10.9% 
18 
6.9% 
Lower abdominal pain 
count 
% of total 
1 
 
8.3% 
14 
 
7% 
2 
 
4.3% 
17 
 
6.6% 
Re- insertion count 
% of total 
1 
8.3% 
0 
0% 
0 
0% 
1 
0.4% 
Permanent sterlisation 
count 
% of total 
1 
 
8.3% 
2 
 
1% 
0 
 
0% 
3 
 
1.2% 
Removed count 
% of total 
0 
0% 
6 
3% 
1 
3.2% 
7 
2.7% 
 
TOTAL 
12 
4.6% 
201 
77.6% 
46 
17.8% 
259 
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According to the above data, there is significant association 
between socioconomic status and complications (p<0.002).there 
are more complications in the lower socioeconomic class.for 
eg.intermenstrual spotting is 16.7% in < 2000 income group 
patients, even though they count only 12 members. 
 
SOCIOECONOMIC STATUS & COMPLICATIONS 
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TABLE 20  
EDUCATION &COMPLICATIONS 
 
COMPLICATIONS 
EDUCATION 
TOTAL 
Illiterate Primary Middle 
High 
school 
Graduate 
Nil count 
% of total 
15 
78.9% 
62 
92.5% 
82 
79.6% 
28 
71.8% 
21 
67.7% 
208 
80.3% 
Intermenstrual 
spotting count 
% of total 
2 
10.5% 
2 
3% 
8 
7.8% 
2 
5.1% 
4 
12.9% 
18 
6.9% 
Expulsion count 
% of total 
0 
.0% 
1 
1.5% 
1 
1% 
2 
5.1% 
1 
3.2% 
5 
1.9% 
White discharge 
count 
% of total 
2 
10.5% 
2 
3% 
7 
6.8% 
2 
7.7% 
3 
9.7% 
17 
6.6% 
Expulsion followed 
reinsertion count 
% of total 
0 
.0% 
0 
.0% 
0 
.0% 
1 
2.6% 
0 
.0% 
1 
0.4% 
Permanent 
sterilisation count 
% of total 
0 
.0% 
0 
.0% 
3 
2.9% 
0 
.0% 
0 
.0% 
3 
1.2% 
Removed count 
% of total 
0 
.0% 
0 
.0% 
2 
1.9% 
3 
7.7% 
2 
6.5% 
7 
2.7% 
TOTAL 
19 
7.3% 
67 
25.9% 
103 
39.8% 
39 
15% 
31 
12% 
259 
100% 
In the above data, the complications are more with the highly educated 
persons.so education is not a significant factor.p=0.050. 
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TABLE 21 
CROSS TABULATION MODE OF DELIVERY & 
COMPLICATIONS 
COMPLICATIONS 
MODE OF DELIVERY 
TOTAL Labour 
natural 
Instrument
al delivery 
Cesarean 
section 
Nil count 
% of total 
55 
84.6% 
 
2 
100.0% 
151 
78.6% 
208 
80.3% 
Intermenstrual 
spotting count 
% of total 
2 
3.1% 
 
0 
.0% 
16 
8.3% 
18 
6.9% 
Expulsion not 
reinsertion count 
% of total 
3 
4.6% 
0 
.0% 
2 
1.04% 
5 
1.9% 
Expulsion reinsertion 
count 
% of total 
0 
.0% 
0 
.0% 
1 
0.5% 
1 
0.4% 
White discharge 
count 
% of total 
3 
4.6% 
0 
.0% 
14 
7.3% 
17 
6.6% 
Permanent 
sterilisation count 
% of total 
1 
1.5% 
0 
.0% 
2 
1% 
3 
1.2% 
Removed count 
% of total 
1 
1.5% 
0 
.0% 
6 
3.1% 
7 
2.7% 
TOTAL 
65 
25.1% 
2 
0.7% 
192 
74.1% 
259 
100% 
According to the above data, p >0.5, so mode of delivery is not a 
significant factor for the development of complications.cesaren 
delivery has more complications, when compared to labour natural. 
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TABLE 22 
CROSS TABULATIION FOLLOW UP & COMPLICATIONS 
COMPLICATIONS 
PERCENTAGE 
At 3 months At 6 months At 12 months 
Nil 80.7% 95.6% 93.2% 
Intermenstrual spotting 7.3% 5.24% 2.7% 
Expulsion  no reinsertion 2.3% - - 
Expulsion reinsertion 0.5% 0.4% - 
White discharge 6.9% 5.24% 2.2% 
Permanent sterilisation 0.9% 0.4% - 
removed 1.4% 1.7% - 
TOTAL 72.6% 76.3% 74.3% 
Most of the complications occurred in the first 3 months itself,with the 
cumulative expulsion rate of 2.8% and as the duration  from the time of 
insertion increases, the complication decreases, with the continuation rate 
of 93.2 % with out any complications. 
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TABLE 23 
CROSS TABULATION TIME OF INSERTION & 
COMPLICATIONS 
COMPLICATIONS INTRA-CESAREAN PERCENTAGE 
nil 151 78.6% 
Intermenstrual spotting 16 8.4% 
Expulsion not reinserted 2 1% 
Expulsion reinsertion 1 0.5% 
White discharge 14 7.3% 
Permanent sterilisation 2 1.0% 
Removed 6 3.1% 
Total 192 74.1% 
From the above data, even though 78.6% of intracesarean insertions have 
no complications, and expulsion is 1% removal rate is 3.1 %, which is 
due to medical complications. 
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TABLE 24 
COMPLICATIONS WITHIN 10 MINUTES PERCENTAGE 
Nil 32 91.4% 
Intermenstrual spotting 1 2.9% 
Expulsion no reinsertion & 
reinsertion 
0 .0% 
White discharge 2 5.8% 
removed 0 .0% 
Total 35 100% 
There are no expulsions and removal rate inspite of woman having 
intermenstrual spotting 2.9% & white discharge 5.8%. 
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TABLE 25 
COMPLICATIONS 
48 HOURS 
POSTPARTUM 
PERCENTAGE 
Nil 26 78.8% 
Intermenstrual 1 3.0% 
Expulsion no reinsertion 3 9% 
White discharge 1 3.0% 
Permanent sterilisation 1 3.0% 
Removed 1 3.0% 
Total 33 100% 
In this data,among the 33 persons inserted 48 hours postpartum, the 
expulsion & removal rate is 9% which is high when compared to the 
intracesaren and within 10 minutes insertion. 
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TABLE 26 
CROSS TABULATION EXCLUSIVE BREAST FEEDING 
& REGAINED CYCLES 
EXCLUSIVE 
BREAST 
FEEDING 
REGAINED MENSTRUAL CYCLES 
TOTAL 
yes no 
Yes count 
% of total 
52 
73.2% 
163 
86.7% 
215 
83% 
No count 
% of total 
19 
26.8% 
25 
13.3% 
44 
17% 
Total 71 188 
259 
100% 
Out of 259 woman,  only 215(83%) have breast fed exclusively for 6 
months. 
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TABLE 27 
BREAST FEEDING AND COMPLICATIONS 
COMPLICATIONS 
EXCLUSIVE BREAST FEEDING 
PERCENTAGE 
yes no 
Nil 82.7% 17.3% 
Intermenstrual spotting 94.4% 5.6% 
Expulsion no reinsertion 100% 0% 
Expulsion reinsertion 100% 0% 
White discharge 88.2% 11.8% 
Permanent sterilisation 66.7% 33.3% 
removed 42..9% 57.1% 
Total 83% 17% 
Here, the p value is>0.05.therefore exclusive breastfeeding does not 
decreases the complications, so it is not significant factor in reducing the 
complication 
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TABLE 28 
AMENORRHEA AND COMPLICATIONS 
COMPLICATIONS 
MENSTRUAL CYCLES 
PERCENTAGE 
AMENORRHOEA 
REGAINED 
CYCLES 
Nil 86.7% 63.4% 
Intermenstrual spotting - 88.9% 
Expulsion no reinsertion 0.5% 5.6% 
Expulsion reinsertion 0.0% 1.4% 
White discharge 8.5% 1.4% 
Permanent sterilisation 0.5% 2.8% 
Removed 2.7% 
2.8% 
 
Total 72.6% 27.4% 
According to the above data, there is significant association between 
amenorrhea and the reduced complications(p <0.000) 
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TIME OF INSERTION AND THREAD VISIBILITY 
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TABLE 29 
TIME OF INSERTION AND THREAD VISIBILITY 
CROSS TABULATION 
TIME OF INSERTION 
THREAD VISIBILITY Total 
Yes No 
Within 10 minutes count 
 
% of total 
33 
 
94.3% 
2 
 
5.7% 
35 
 
14.3% 
Intra-cesarean count 
 
% of total 
87 
 
48.6% 
92 
 
51.4% 
179 
 
73.4% 
48 hours postpartum count 
 
% of total 
30 
 
100% 
0 
 
0% 
30 
 
12.3% 
Total 
 
 
 
150 
 
61.5% 
94 
 
38.5% 
244 
 
100% 
According to the above data, there is a significant association(p<0.000) 
between time of insertion and thread visibility.within 10 minutes of 
placental delivery, the IUCD insertion shows increased thread visibility. 
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TABLE 30 
MEDICAL DISORDER WITH COMPLICATIONS. 
COMPLICATIONS 
PERCENTAGE 
anaem
ia 
GD
M 
Heart 
disease 
hypothyroidism 
Menstrual problems 18.2 0 20 
12.5 
expulsion 9.1 14.3 0 
0 
White discharge 0 14.3 0 
25 
removed o 0 20 
0 
From the above data, the menstrual problems are more in anaemic 
patients when compared to other medical disorder.p>0.5 it is not 
statistically significant. 
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DISSCUSION 
  This study highlights the safety and efficacy of postpartum 
insertion of intra uterine device copper T 380A among the parturitents 
and followed up for 1 year.Totally 300 woman were included in the study 
and IUCDS were inserted based on  the medical eligibility criteria  after 
getting written informed consent.Insertion of PPIUCD was done after 
excluding woman who came with draining per vaginum for >12 hours, 
maternal fever,uterine anamolies,fibroid uterrus, post partum 
haemorrhage- atonic/traumatic and systemic examination was done given 
in the proforma. 
 Out of 300 woman, only 259 returned for follow up..They are  
given education regarding complications at discharge and counselled for 
follow up at 3 months and 6months and at 12months. 
 Almost 218 woman returned for follow up at 3 months, 229 
returned at the end of 6 months and  223 at the end of 12 months.During 
the follow up a detailed history was taken as per the proforma enclosed 
and thorough general and systemic examination  and speculum 
examination was done for the presence or absence of CopperT inside the 
uterus by visualisation of the copper T thread. If the threads were 
missing, then immediate trans abdominal ultrsonogram was done to 
 
 
74 
 
identify whether copperT was expulsed, or perforated. Out of the259 
persons,we were able to see the threads  for 150 women. For remainig 
109 clients,threads were not visible.of which  7 removed due to pain 
abdomen,3 turned out to permanent sterilisation,and 5 had spontaneous 
expulsion.so trans abdominal sonogram was done in both remaining 94 
women and 5 spontaneous expulsion to see whether IUCD has perforated, 
embedded in the myometrium or expulsed.Findings were, in the 5 
spontaneous expulsion women, there was no Copper T inside the 
uterus.there are neither perforation nor expulsion in the remaining 94 
women. 
 The mean age  of woman in the study was 24 years.About 71.7% of 
the woman are exclusively breast feeding. 
 Followup rate is 74.3%. (i.e)percentage of woman not terminated or  
returned  at the and of 1 year. 
 The mean education is middle school. 
 The mean age of live birth is primipara. 
 Caliskan et al, 2003, analysed the risk factors associated with IUCD 
insertion.   All 8343 women were examined by ultrasound  after 1 
year.  The risk of uterine perforation are more in 0-3 months 
postpartum than immediate postplacental and  after 6 months 
postpartum with OR 13.2, 11.7 respectively.  The risk decreases as 
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the parity increases OR 0.04. In our study, there were no uterine 
perforations at the of 12 months  as all are immediate postpartum 
insertion.so also as the parity increases with more than 3 and above, 
there are no complications. 
  literature  shows that there are increased risk of uterine perforation 
in breast feeding women.In our data,there are no perforations during 
postplacental insertions which was due to the predictable size and 
consistency of the uterus at these times irrespective of their breast 
feeding pattern. But all 5 spontaneous expulsion occurred in breast 
feeding women which may be due to   contractility  of the uterus 
secondary to oxytocin and prolactin release. 
 
 Ansari’s study shows that uterine perforation caused by an IUD may 
be secondary to incomplete perforation following primary 
weakening of the uterine wall due to damage inflicted by the metal 
sound which is not needed in immediate postpartal insertion of an 
PPIUCD. 
 
 S evki  Celen et al Turkey 2004, Clinical outcomes of early 
postplacental insertion.i.e. within 10 minutes in vaginal and cesarean 
deliveries via a ring forceps. Of the 276 patients enrolled, 235 were 
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included in the study. Recipients were scheduled for examination 
before hospital discharge and at 6 weeks, 6 months and 12 months 
after postplacental insertion. The percentages of women returning for 
a follow-up visit were 221 (94%), 210 (89%) and 183 (78%) at 6 
weeks, 6 months and 12 months, respectively. Among IUD 
acceptors, 74% of the cases had vaginal deliveries and 26% had 
cesarean deliveries. Continuation rates were relatively high, 87.6% 
and 76.3%, at 6 and 12 months, respectively. In this study, the 1-year 
cumulative expulsion rate with TCu 380A device was 12.3%, which 
may be regarded as a standard expulsion rate for immediate 
postplacental insertion.In our study, the follow up rate at 3months, 6 
months and at 12 months are 72.6%,76.3%, 74.3% respectively.The 
continuation rates at 6& 12 months are-95.6%, 93.2% 
respectively.the cumulative expulsion rate is 2%. 
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SUMMARY 
The study was undertaken in 300 parturitents who were willing for 
PPIUCD. On admission the parturitents were recruited based on the 
medical eligibility criteria.women were excluded from the study if they 
had ruptured membranes for > 12 hours, any haemorrhagic disorder, 
maternal fever, uterine anamolies, myoma uterus and postpartum 
haemorrhage.PPIUCD was inserted after getting an written informed 
consent. The purpose of the study was to determine the safety and 
efficacy of PPIUCD among the parturitents. Safety means failure rate 
(pregnancy rate), and efficacy is continuation rate. 
A detailed history was elicited as per the proforma enclosed and 
thorough general and systemic examination was done before PPIUCD 
insertion and during follow up. The results are interpreted by chi- square 
tests. 
The mean age of woman in the study was 24 years. 54% of woman 
in the study  are in the 21-24 years age group.as the number of persons in 
this group are more, the occurrence of complications will also be tend to 
be higher so age is not a significant factor in determining the efficacy. 
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In our study only 12 Women (4.6%)belong to the low income  
group of < 2000 per month . Because of low socioeconomic 
status,woman in these group have higher  incidence of menstrual 
problems (16.7%),and white discharge (8.3%) which is comparable to the 
high income group. Also they  doesn’t want more children, which made 
them to opt for permanent sterilization (8.3%).so socioeconomic status 
according to income is a significant factor.(p-0.000) in continuation of 
IUCD. 
In educated persons, the continuation rate should be  more when 
compared to the illiterate persons. But here it is opposite, where the 
discontinuation rate due to removal is 6.5%. 
Most of the complications occurred in the first 3 months of 
insertion, 2.8%  expulsion. When the duration from the time of insertion 
increases, the complication decreases for example- inter menstrual 
spotting 7.3% at 3 months decreased to 2.7 % at 12 months of follow up 
with the continuation rate of 74.3% . 
According to the time of insertion intra cesarean insertion has an 
expulsion rate of 1%,and in 48 hours postpartum has high expulsion rate 
of 9 %,which may be due to the technique of insertion. 
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Among 232 intra cesarean insertion, 192 came for follow up, for 
51.4% threads were not visible on per speculum examination. 
In our study, there are no pregnancy rate nor perforations at the end 
of 1 year. Efficacy is dependent on the the continuation rate. The 
discontinuation rate means it includes both spontaneous expulsion and 
removal due to medical problems. 
Cumulative expulsion 2%.(1.7+0.3%) 
Cumulative Removal rate 2.3% 
Menstrual complaints 6% 
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CONCLUSION 
Our study highlights the following, 
 There is no significant association between age, parity, or 
education and the efficacy of PPIUCD. 
 
 Women from low socioecomic group has increased incidence of 
menstrual problems and white discharge . 
 
 Even though 48 hours postpartum is safe for IUCD insertion, there 
are 9% expulsion rate, when compared to immediate within 10 
minutes insertion (includes intracesarean-1%, following labour 
natural – nil ) expulsion.so it signifies that the technique and time 
of insertion plays a significant factor in the continuation rate. 
 
 As there are no untoward complications like pregnancy nor 
perforations with minimal  expulsion rate of 1.7% and removal rate 
of 2.3%, PPIUCD is the most safe and highly efficacious mode of 
population control and provides a healthy birth spacing,there by 
decreasing the unmet need for family planning. 
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 Majority of the PPIUCD were inserted after proper counseling 
(68%),only 0.3% underwent reinsertion following spontaneous 
expulsion, which indicates that even more information regarding 
the advantages and disadvantages of the all available methods and 
PPIUCD have to be explained to decrease the unmet need of the 
family planning services. 
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ABBREVATIONS 
 
PPIUCD - Postpartum insertion of intrauterine device 
IUCD  -  Intrauterine device. 
NFHS - National  Family Health Survey 
GOI  - Government of India 
OCP  - Oral contraceptive pills 
JHPIEGO - Johns Hopkins Program for International  
   Education in Gynaecology and Obstetrics. 
CuT  - Copper T 
OR  - Odds ratio 
MEC  - Medical Eligibilty Criteria 
ICMR - Indian Council of Medical Research 
NSAID’S - NonSteroidal Anti inflammatory Drugs 
LNG  - Levonorgestrol 
CI  - Confidence Limits 
MLCu - Multiload copper 
EP   -    Early postpartum 
IPP  - Immediate postplacental 
INT  - Interval 
PID  - Pelvic inflammatory disease 
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PROFORMA 
SERIAL NO. 
HOSPITAL NO. 
 
Name    :                             Address  :                                         
Age    :   Education  : 
Socioeconomic status :   Occupation   : 
Obstetric score  : 
Present history  : 
Menstrual history  : age of menarche,regular/irregular  
     cycles 
Marital history  : 
Obstetric history  : 
Previous history of 
 contraceptive use  : 
Past history   : 
Personal history  : 
Counselling   :  antepartum/intrapartum  
 
General examination : 
 Afebrile 
 Anaemic/not 
 No pedal edema 
 Vitals-Temp, Pulse rate, RR, Blood Pressure  
 CVS/RS- normal 
 According to the mode of delivery- PPIUCD is 
inserted. 
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Investigations: 
Urine –albumin, sugar , deposits 
Complete hemogram 
Renal,liver function tests 
Blood grouping & typing. 
 
On discharge: 
After thorough general examination, per speculum examination is 
done. Only for 48 hours postpartum, threads are trimmed. 
Advice  given on exclusive breast feeding, 
 any lower abdominal pain 
 abnormal discharge 
 fever 
 expulsion 
 To come for  follow up  at 3months, 6months and 12 
months. 
 
PROFORMA FOR FOLLOW UP 
Name  
Age 
 Follow up At 3 
months 
At 6 months At 12 months 
 
Parity 
Compliants of:  
 spotting/bleeding per vaginum 
 dysmenorrhoea 
 lower abdominal pain  
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  low backache 
 White discharge 
 Expulsion 
 Causes for removal 
 Perforation 
 Pregnancy. 
Breast feeding: Exclusively/not.How long. What are the alternatives 
given. 
Menstrual history:  
Regained cycles/not. If regained cycles- when, flow. 
Spotting/bleeding,associated with pain abdomen,any inter menstrual 
distubances present. 
General examination:  
 Afebrile 
 Anaemic 
 Pedal edema 
 Vitals-  temperature,BP, pulse,  
 CVS/RS 
 Per abdomen examination:warmthness, tenderness,uterine size- 
involution 
 Per speculum examination- lochia, abnormal discharge,thread 
visible/not.If visible the threads are trimmed. 
If threads are not visible , they are subjected to trans abdominal 
examination – to rule out expulsion and perforation  
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CONSENT FORM 
STUDY TITLE  :   EFFICACY AND SAFETY OF PPIUCD 
                                             AMONG PARTURIENTS                                           
STUDY CENTRE :  Institute of Social obstetrics and Govt., KGH, 
Chennai 
Participant Name :  Age :    Sex:    I.P.No 
I confirm that I have understood the purpose of procedure  for the above 
study, I have the opportunity to ask the question and all my questions and 
doubts have been answered to my satisfaction. 
I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving any reason. 
I understand that investigator, regulatory authorities, and the ethics 
committee will not need my permission to look at my health records both in 
respect to the current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study. I understand that my identity 
will not be revealed in any information released to third parties of published, 
unless as required under the law. I agree not to restrict the use of any or results 
that arise from the study. 
I hereby consent to participate in this study of efficacy and safety of 
ppiucd among parturitents 
Signature of Investigator:      Place: 
 Date : 
Study Investigators Name      Institution 
Signature /Thumb Impression of patient    Place : 
Date : 
Signature of witness  
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